Sulfonamide-Terminated Phosphonic Acid-Based Double Hydrophilic Block Copolymers Forming Phosphate-Resistant Lanthanide-Coordinated Hybrid Polyionic Nanostructures with Antibacterial Activity
Source abstract
Abstract
Sulfonamide-terminated double hydrophilic block copolymers (DHBCs) composed of poly(oligo(ethylene glycol) acrylate) (POEGA) and poly(vinylphosphonic acid) (PVPA) were synthesized by RAFT polymerization and used to form hybrid polyionic complexes (HPICs) with trivalent lanthanide ions (Gd 3+ or Eu 3+ ). These HPICs self-assembled into stable, well-defined colloidal nanostructures under physiological conditions, driven by strong PVPA–lanthanide coordination. Eu 3+ luminescence studies revealed a robust coordination environment resistant to competitive phosphate ions, in contrast with poly(acrylic acid) (PAA)-based analogues. Both the functionalized polymers and their HPICs exhibited antibacterial activity against Pseudomonas aeruginosa and Staphylococcus aureus . Moreover, the Gd 3+ -based HPICs showed high longitudinal relaxivity values comparable to clinical MRI contrast agents and remained stable over a wide pH range, highlighting their potential as multifunctional theranostic nanoplatforms.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Lanthanide and Transition Metal Complexes · Nanoparticle-Based Drug Delivery · Advanced Polymer Synthesis and Characterization
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
CNRS UMR 5623, Laboratoire Softmat, Université de Toulouse, 118 route de Narbonne, 31062 Toulouse, France
Université de Toulouse, INPT, CNRS UMR 5503, Laboratoire LGC, 35 chemin des Maraîchers, 31400 Toulouse, France
CNRS UMR 5068, Laboratoire SPCMIB, Université de Toulouse, 118 route de Narbonne, 31062 Toulouse, France
Funding
Agence Nationale de la Recherche
References (33)
Show source-provided references
1. 10.1021/acs.chemrev.3c0070510.1021/acs.chemrev.3c00705 ↗
2. 10.1038/s41392-023-01642-x10.1038/s41392-023-01642-x ↗
3. 10.1021/acs.chemrev.5b0058910.1021/acs.chemrev.5b00589 ↗
4. 10.1055/s-0039-169015410.1055/s-0039-1690154 ↗
5. 10.1016/j.chempr.2023.08.01010.1016/j.chempr.2023.08.010 ↗
6. 10.3390/polym1312202210.3390/polym13122022 ↗
7. 10.1039/D1PY01172C10.1039/D1PY01172C ↗
8. 10.1007/s12551-021-00795-910.1007/s12551-021-00795-9 ↗
9. 10.1021/acs.jmedchem.6b0062310.1021/acs.jmedchem.6b00623 ↗
10. 10.1371/journal.pone.005086010.1371/journal.pone.0050860 ↗
11. 10.1159/00048716210.1159/000487162 ↗
12. 10.3390/metabo801001310.3390/metabo8010013 ↗
13. Yaoita H. · J. Nucl. Med. · 1993 · 34 · 1303
14. 10.1039/D3PY00629H10.1039/D3PY00629H ↗
15. 10.1021/acs.nanolett.6b0066410.1021/acs.nanolett.6b00664 ↗
16. 10.1016/j.jcis.2023.06.11610.1016/j.jcis.2023.06.116 ↗
17. 10.1021/acsmacrolett.2c0048910.1021/acsmacrolett.2c00489 ↗
18. 10.1016/j.eurpolymj.2024.11296310.1016/j.eurpolymj.2024.112963 ↗
19. 10.1021/ic00316a02310.1021/ic00316a023 ↗
20. 10.1039/D0PY00838A10.1039/D0PY00838A ↗
21. 10.1016/j.cis.2022.10280810.1016/j.cis.2022.102808 ↗
22. 10.1039/c2py00541g10.1039/c2py00541g ↗
23. 10.1002/marc.20060051310.1002/marc.200600513 ↗
24. 10.1021/acsanm.1c0049510.1021/acsanm.1c00495 ↗
25. 10.1039/D4NR04332D10.1039/D4NR04332D ↗
26. 10.1039/C6PY01558A10.1039/C6PY01558A ↗
27. Cotton S. · 200610.1002/0470010088 ↗
28. 10.1016/j.ccr.2015.02.01510.1016/j.ccr.2015.02.015 ↗
29. 10.1007/s00775-022-01930-x10.1007/s00775-022-01930-x ↗
30. 10.1101/cshperspect.a02526210.1101/cshperspect.a025262 ↗
31. 10.1038/s42004-025-01510-510.1038/s42004-025-01510-5 ↗
32. 10.1039/D5NR00986C10.1039/D5NR00986C ↗
33. 10.1039/D3NR06162K10.1039/D3NR06162K ↗